AstraZeneca's $1.5B US Investment, UK Concerns

AstraZeneca, the UKs largest company, is investing £1.5 billion in the US, expanding its Maryland manufacturing base. This move follows the companys decision to put two major UK projects on hold, raising concerns about investment in the UK. AstraZenecas CEO has expressed worries about the UKs competitiveness, and upcoming budget announcements could further impact future investment decisions.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.